Published in Bioorg Khim on March 01, 1994
Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett (1993) 3.30
Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model. Antimicrob Agents Chemother (1997) 1.71
Inter- and intraquinolone predictors of antimicrobial effect in an in vitro dynamic model: new insight into a widely used concept. Antimicrob Agents Chemother (1998) 1.37
A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities. Antimicrob Agents Chemother (1998) 0.88
[Inhibition of cathepsin G and elastase from human granulocytes by multiple forms of the Bowman-Birk type of soy inhibitor]. Biokhimiia (1993) 0.88
MIC-based interspecies prediction of the antimicrobial effects of ciprofloxacin on bacteria of different susceptibilities in an in vitro dynamic model. Antimicrob Agents Chemother (1998) 0.85
Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme. Biochemistry (Mosc) (1999) 0.81
[Characteristics of monoclonal antibody binding with the C domain of human angiotensin converting enzyme]. Bioorg Khim (2008) 0.80
[The classical Bowman-Birk soy inhibitor is an effective inhibitor of human granulocyte alpha-chymotrypsin and cathepsin G]. Biokhimiia (1994) 0.78
[Inhibition of elastin hydrolysis, catalyzed by human leukocyte elastase and cathepsin G, by the Bowman-Birk type soy inhibitor]. Biokhimiia (1994) 0.78
Role of two chloride-binding sites in functioning of testicular angiotensin-converting enzyme. Biochemistry (Mosc) (2005) 0.78
[Detection of natural anti-angiotensin converting enzyme antibodies in human serum using immunoenzyme technique ]. Klin Lab Diagn (2000) 0.77
Isolation and characterization of the N-domain of bovine angiotensin-converting enzyme. Biochemistry (Mosc) (2000) 0.77
Fluorescence polarization studies of different forms of angiotensin-converting enzyme. Biochemistry (Mosc) (2001) 0.77
[Interaction of 4 active forms of trypsin with specific substrate and pancreatic inhibitor]. Biokhimiia (1971) 0.77
Unusual behavior of membrane somatic angiotensin-converting enzyme in a reversed micelle system. Biochemistry (Mosc) (2001) 0.77
Characterization of bovine atrial angiotensin-converting enzyme. Biochemistry (Mosc) (2001) 0.77
[Intergeneric hydridization of the actinomycetes Streptoverticillium mycoheptinicum and Streptomyces coelicolor]. Mikrobiologiia (1984) 0.76
[Oxidative stress in uveitis and its correction with superoxide dismutase antioxidative enzyme (experimental study)]. Vestn Oftalmol (2015) 0.76
[Tuberculosis of the respiratory tract and chronic alcoholism]. Probl Tuberk (2001) 0.76
[Mental rationale for local use of angiotensin-converting enzyme in the treatment of inflammatory processes in the eye]. Vestn Oftalmol (2008) 0.75
[Biosynthesis of L-lysine-alpha-oxidase, an antitumor enzyme, by Trichoderma spp]. Antibiot Khimioter (2009) 0.75
[Methods of determination of equilibrium and kinetic parameters for the interaction of protein inhibitors with proteinases]. Biokhimiia (1979) 0.75
[Azoalbumin hydrolysis by Bacillus subtilis 72 subtilisin]. Prikl Biokhim Mikrobiol (1982) 0.75
[Microcolorimetric study of the association of trypsin with a pancreatic inhibitor]. Biokhimiia (1976) 0.75
[Activity of angiotensin-converting enzyme in the rabbit lacrimal fluid after burn of the cornea]. Vopr Med Khim (1997) 0.75
[Optical rotatory dispersion of trypsin, pancreatic trypsin inhibitor and their complex]. Biokhimiia (1971) 0.75
[Fibrinolysis in vitro by acylated derivatives of a plasmin-streptokinase activator complex]. Ukr Biokhim Zh (1978) (1991) 0.75
Structural organization of membrane and soluble forms of somatic angiotensin-converting enzyme. Biochemistry (Mosc) (1999) 0.75
[Electroreduction of S-S-linkages in alpha-chymotrypsin]. Biokhimiia (1968) 0.75
[Catalytic properties of plasmin and the equimolar plasmin-streptokinase complex in their reactions with various substrates and inhibitors]. Ukr Biokhim Zh (1978) (1991) 0.75
[Retention of the enzyme activity of alpha-chymotrypsin following cleavage of the disulfide bond between B and C chains]. Dokl Akad Nauk SSSR (1972) 0.75
[Production of timolol containing calcium-phosphate nanoparticles and evaluation of their effect on intraocular pressure in experiment]. Vestn Oftalmol (2012) 0.75
[Inhibitors as factors regulating proteolysis]. Bioorg Khim (1994) 0.75
[Properties of alpha-chymotrypsin, covalently incorporated into polyacrylamide microgranules]. Biokhimiia (1980) 0.75
[Determination of solvent accessibility of residues of aromatic amino acids in proteins using the second derivative of the UV-absorption spectrum]. Biokhimiia (1994) 0.75
[Physico-chemical characteristics of angiotensin-converting enzyme from the bovine lung]. Biokhimiia (1990) 0.75
[Structure-functional features of homologous domains of angiotensin-converting enzyme]. Bioorg Khim (2003) 0.75
[Soluble high molecular weight derivatives of pancreatic inhibitors. Kinetic-thermodynamic studies of inhibitors linked to differently charged matrices]. Biokhimiia (1979) 0.75
[Use of immobilized enzymes and their natural inhibitors in surgery]. Khirurgiia (Mosk) (1983) 0.75
[Isolation and properties of acylplasmin]. Vopr Med Khim (1985) 0.75
[Processes of alkaline proteinase denaturation in Bacillus subtilis under various conditions]. Prikl Biokhim Mikrobiol (1982) 0.75
[Autoantibodies to vasoactive peptides and angiotensin converting enzyme in patients with systemic diseases of the connective tissue]. Ter Arkh (2001) 0.75
[Photic initiation of low-molecular substrate hydrolysis during autocatalytic enzyme reproduction]. Dokl Akad Nauk SSSR (1974) 0.75
[Microgranulated form of cis-cinnamoylchymotrypsin for half-tone enzyme photography]. Biokhimiia (1981) 0.75
[Anomalous temperature dependence of the activity of immobilized alpha-chymotrypsin preparations]. Bioorg Khim (1994) 0.75
[Radiation activation of angiotensin-converting enzyme during low-dose irradiation]. Radiats Biol Radioecol (1999) 0.75
A hydrophobic site on the surface of the angiotensin-converting enzyme molecule. Biochemistry (Mosc) (2002) 0.75
[The thrombolytic activity of acylated activator complexes of plasmin-streptokinase with different rates of reactivation]. Farmakol Toksikol (1991) 0.75
[Function of angiotensin-converting enzyme on matrices]. Biokhimiia (1990) 0.75
[Natural proteinase inhibitors as a basis for creating new drugs]. Vopr Med Khim (1994) 0.75
[Comparative physico-chemical characterization of high polymer deoxyribonucleic acids from actinomycetes and Bacillus breslau]. Mikrobiologiia (1967) 0.75
[Experimental validation of licopin-containing drug tomatol use in combined therapy of patients with diabetic retinopathy]. Vestn Oftalmol (2001) 0.75
[Properties of alpha-chymotrypsin and cis-cinnamoylchymotrypsin in free, covalently bound to a carrier and microcapsulated states]. Biokhimiia (1977) 0.75
Energy metabolism in rat brain structures after injections of kainic acid into the frontal cortex. Bull Exp Biol Med (2007) 0.75
[Initiation of autoactivation of trypsinogen using light-sensitive trans-n-(N,N,N-trimethylamino)-cinnamoyltrypsin]. Biokhimiia (1974) 0.75
[Structure of the active center of subtilisin 72]. Biokhimiia (1982) 0.75
[Immobilization of modified alpha-chymotrypsin within the structure of cellulose triacetate membranes]. Biokhimiia (1980) 0.75
[Effectiveness of acylated thrombolytic agents in lysis of blood plasma clots from humans and various animals]. Ukr Biokhim Zh (1978) (1991) 0.75
[Angiotensin-converting enzyme in an OAT-octane reversed micelle system: interaction with the matrix]. Bioorg Khim (1995) 0.75
[Radioenzymatic investigation of membrane and soluble forms of angiotensin-converting enzyme in acetate-phosphate buffer]. Radiats Biol Radioecol (2003) 0.75
[Soluble high molecular weight derivatives of pancreatic trypsin inhibitor. Modification of pancreatic trypsin inhibitor by soluble polysaccharides activated by titanium tetrachloride]. Biokhimiia (1980) 0.75
[Activity of angiotensin-converting enzyme in the blood and tear of patients with diabetic retinopathy]. Vestn Oftalmol (2006) 0.75
[Properties of alpha-chymotrypsin enclosed into polycarbonate microcapsules. Estimation of the diffusion effect]. Biokhimiia (1977) 0.75
[Kinetics of in vitro fibrinolysis by plasmin and a plasmin-streptokinase equimolar complex]. Ukr Biokhim Zh (1978) (1991) 0.75
[Angiotensin-converting enzyme stability in the presence of zinc-ions different concentrations]. Radiats Biol Radioecol (2009) 0.75
[The role of angiotensin-converting enzyme in pathogenesis of post-contusion disorders of ophthalmotonus and hemodynamics]. Vopr Med Khim (1999) 0.75
[Diagnostic implications of detecting antibodies to angiotensin-converting enzyme and its substrates]. Klin Med (Mosk) (2003) 0.75
[Zinc-dependent angiotensin-converting enzyme in reactions with various enzymes]. Biokhimiia (1990) 0.75
[A method for determining plasmin by the rate of fibrin gel lysis]. Biull Eksp Biol Med (1989) 0.75
[Extraction and properties of microcapsulated alpha-chymotrypsin]. Biokhimiia (1976) 0.75
[Isolation of pancreatic trypsin inhibitor from pantrypine]. Vopr Med Khim (1971) 0.75
[Phase transition in the matrix as a regulator of enzymatic activity of proteinases]. Bioorg Khim (1998) 0.75
[Kinetics of the hydrolysis reaction catalyzing alpha-chymotrypsin and trypsin in the presence of added nucleophilic agents]. Biokhimiia (1971) 0.75
[Soluble high molecular weight derivatives of trypsin pancreatic inhibitor. Isolation and properties of dextran-bound pancreatic inhibitor]. Biokhimiia (1977) 0.75
[Regulation of catalytic activity and supramolecular structure of angiotensin-converting enzyme in reversed micelles of aerosol OT in octane]. Biokhimiia (1994) 0.75
[The in vitro cross-effects of inhibitors of renin-angiotensin and fibrinolytic systems on the key enzymes of these systems]. Bioorg Khim (2008) 0.75
[Structure and biological properties of a conjugate of Bowman-Birk type soy proteinase inhibitor with a block copolymer of ethylene oxide and propylene oxide]. Biokhimiia (1995) 0.75
[The role of the components of the renin-angiotensin system in the ocular tissues in norm and pathology]. Vestn Ross Akad Med Nauk (2003) 0.75
[Kinetics of dissolution of solid protein substrates by proteinases. Selection of the reaction mechanism]. Biokhimiia (1989) 0.75
[APUD- and RAA- regulatory systems in acute radiation injury]. Radiats Biol Radioecol (2001) 0.75
[Interaction of trypsin with a trypsin inhibitor from bovine colostrum]. Biokhimiia (1975) 0.75
[Determination of the equilibrium constant for the reaction between trypsin and trypsin inhibitor from cattle lung tissue]. Biokhimiia (1971) 0.75
[Secondary specificity of alpha-chymotrypsin: hydrolysis of methyl esters of some acetyldipeptides]. Biokhimiia (1971) 0.75
[Experimental rationale for local use of angiotensin-converting enzyme inhibitors for the treatment of ocular tissue ischemia on a model of postburn conjunctival ischemia]. Vestn Oftalmol (2008) 0.75
[A method of calculation of accessibility to solvent of aromatic amino acid residues of proteins in water-organic mixtures]. Biokhimiia (1996) 0.75
[Change of natural antibody levels in patients with cardiovascular diseases by the use of anti-atherogenic diets with processed soy product foods]. Vopr Pitan (2002) 0.75
[Digestion of Luliberine analogues containing D-alanine residue by human gastric juice]. Bioorg Khim (1997) 0.75
[Modified and immobilized preparations of basic polyvalent protease inhibitor for potential medical use]. Vopr Med Khim (1985) 0.75
[A phototested chemical sensor element based on a field transistor]. Dokl Akad Nauk (1993) 0.75
[Bimolecular protein-protein interactions in microcapsules]. Biokhimiia (1980) 0.75
[Mass-transfer and kinetics of microencapsulated alpha-chymotrypsin action]. Biokhimiia (1978) 0.75
[Conjugation of classic Bowman-Birk soy inhibitor with a copolymer of ethylene oxide and propylene oxide]. Biokhimiia (1993) 0.75